ARCHIVES

Group Chairs Seek Role Running NCTN

This article is from The Cancer Letter archive.

Vol. 40 No. 34 | September 12, 2014

Download PDF Visit The Full Archive

Related Articles

Expert Review Of ImClone Protocol Concludes C225 Approval Unlikely.

February 15, 2002

“Landmark” Fundings Reported n Interferon Genes, Ovarian And Pancreas Markers

April 17, 1981

Extent Of Risk Reduction From Ovary Removal Varies According To BRCA Mutation

February 29, 2008

In Brief: Healy Names President, CEO of Red Cross; AMA Supports annual Mammograms for 40+

July 16, 1999

Tamoxifen Makes ER-Negative Breast Cancer Easier To Find

October 31, 2008

DCPC Advisors Okay Omnibus Prevention Program Announcement

January 24, 1992